Therapeutic Asset Ratings

3,232 results matching 1 filter

91,583 assets · 7,906 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
Gefitinib Non-Small Cell Lung Carcinoma	Brigham and Women's Hospital	P4	BB (69)
Ginkgo Biloba Cognitive Disorder	Dr. Willmar Schwabe GmbH & Co. KG	P4	BB (69)
Ginkgo Biloba Extract Cognitive Disorder	Hanyang University	P4	BB (69)
GLY-GLY-GLY-CYS-TYR-PHE-GLN-ASN-CYS-PRO-LYS-GLY-NH2 (4-9 DISULFIDE) Esophageal Varices	General Hospital of Shenyang Military Region	P4	BB (69)
Guilu Erxian Liquid Oligospermia	DongE E Jiao Coporation Limited	P4	BB (69)
HUMAN ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX Inherited Blood Coagulation Disorder	Assiut University	P4	BB (69)
Hydrochlorothiazide Abdominal Obesity-Metabolic Syndrome	UMC Utrecht	P4	BB (69)
Idarubicin Acute Myeloid Leukemia	Institute of Hematology & Blood Diseases Hospital, China	P4	BB (69)
Idarubicin Myelodysplastic Syndrome	OHSU Knight Cancer Institute	P4	BB (69)
Ifosfamide Burkitt Lymphoma	Federal Research Institute of Pediatric Hematology, Oncology and Immunology	P4	BB (69)
IMMUNOGLOBULIN G 1 (HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD 20), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL IDEC-C2B8 .KAPPA.-CHAIN, DIMER Primary Central Nervous System Lymphoma	Ono Pharmaceutical Co., Ltd.	P4	BB (69)
Inositol Infertility Disorder	Kafrelsheikh University	P4	BB (69)
Inotuzumab Ozogamicin Acute Lymphoblastic Leukemia	The First Affiliated Hospital of Soochow University	P4	BB (69)
Intravenous Dexamethsone Osteoarthritis, Hip	Poznan University of Medical Sciences	P4	BB (69)
IOFLUPANE Dementia	Mayo Clinic	P4	BB (69)
Ipilimumab Melanoma	M.D. Anderson Cancer Center	P4	BB (69)
Ipilimumab Renal Carcinoma	Fondazione Policlinico Universitario Agostino Gemelli IRCCS	P4	BB (69)
ipx203 Parkinson Disease	The Cleveland Clinic	P4	BB (69)
LABETALOL Malignant Hypertension	Haseki Training and Research Hospital	P4	BB (69)
LENALIDOMIDE Extranodal Nasal NK/T Cell Lymphoma	Xinhua Hospital, Shanghai Jiao Tong University School of Medicine	P4	BB (69)
LENALIDOMIDE Plasma Cell Myeloma	Universitätsklinikum Hamburg-Eppendorf	P4	BB (69)
LENVATINIB Hepatocellular Carcinoma	Zhejiang Haichang Biotech Co., Ltd.	P4	BB (69)
Letrozole Breast Cancer	National Cancer Institute (NCI)	P4	BB (69)
Letrozole Hormone Receptor-Positive Breast Cancer	Universitaire Ziekenhuizen KU Leuven	P4	BB (69)
LEUPROLIDE Breast Cancer	Fudan University	P4	BB (69)

Showing 1076 to 1100 of 3,232 assets

PreviousPage 44 of 130Next